Financials

  • Market Capitalization 264.19 M
  • Employee 34
  • Founded 2004
  • CEO Christopher U. Missling Ph.D.
  • Website www.anavex.com
  • Headquarter New York, United States
  • FIGI BBG000C9K8K4
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.87
市销率
63.29

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3405
MGNX
MacroGenics, Inc. - Common Stock
4.25 USD-1.62%+4.68%+8.42%+114.65%270.73 M USD
3419
SRZN
Surrozen, Inc. - Common Stock
22.54 USD-0.27%-4.17%+0.40%+70.11%264.93 M USD
3426
WHWK
Whitehawk Therapeutics, Inc. - Common Stock
4.63 USD-1.70%-4.93%+11.57%+53.82%263.95 M USD
3437
YDES
YD Bio Limited - Ordinary Shares
3.67 USD-5.90%-6.85%+63.11%-75.20%259.80 M USD

新闻